To demonstrate that T-cell activation following Treg depletion influences intratumoral HEV neogenesis, Treg-depleted fibrosarcoma bearing mice were treated with anti-CD4 and anti-CD8 antibodies. The gene discussed is CD4; the disease is fibrosarcoma.